[HTML][HTML] MicroRNAs (miRNAs) and long non-coding RNAs (lncRNAs) as new tools for cancer therapy: first steps from bench to bedside

M Ratti, A Lampis, M Ghidini, M Salati, MB Mirchev… - Targeted …, 2020 - Springer
Non-coding RNAs represent a significant proportion of the human genome. After having
been considered as 'junk'for a long time, non-coding RNAs are now well established as …

[HTML][HTML] Non-coding RNAs in cancer initiation and progression and as novel biomarkers

SP Nana-Sinkam, CM Croce - Molecular oncology, 2011 - Elsevier
Cancer represents a complex group of heterogeneous diseases. While many cancers share
fundamental biological processes (hallmarks of cancer) necessary for their development …

[HTML][HTML] Noncoding RNAs in cancer and cancer stem cells

T Huang, A Alvarez, B Hu, SY Cheng - Chinese journal of cancer, 2013 - ncbi.nlm.nih.gov
In recent years, it has become increasingly apparent that noncoding RNAs (ncRNA) are of
crucial importance for human cancer. The functional relevance of ncRNAs is particularly …

[HTML][HTML] MicroRNAs and long non-coding RNAs: prospects in diagnostics and therapy of cancer

N Hauptman, D Glavac - Radiology and oncology, 2013 - sciendo.com
Background. Non-coding RNAs (ncRNAs) are key regulatory molecules in cellular
processes, and are potential biomarkers in many diseases. Currently, microRNAs and long …

Therapeutic targeting of non-coding RNAs in cancer

O Slaby, R Laga, O Sedlacek - Biochemical journal, 2017 - portlandpress.com
The majority of the human genome encodes RNAs that do not code for proteins. These non-
coding RNAs (ncRNAs) affect normal expression of the genes, including oncogenes and …

[HTML][HTML] microRNA therapeutics in cancer—an emerging concept

MY Shah, A Ferrajoli, AK Sood, G Lopez-Berestein… - …, 2016 - thelancet.com
MicroRNAs (miRNAs) are an evolutionarily conserved class of small, regulatory non-coding
RNAs that negatively regulate protein coding gene and other non-coding transcripts …

MicroRNAs and cancer—new paradigms in molecular oncology

M Negrini, MS Nicoloso, GA Calin - Current opinion in cell biology, 2009 - Elsevier
The 'classic'view of molecular oncology indicates that cancer is a genetic disease involving
tumor suppressor and oncogenic proteins. However, in the recent years, it has been …

[HTML][HTML] Long non-coding RNAs: Mechanism of action and functional utility

SA Bhat, SM Ahmad, PT Mumtaz, AA Malik… - Non-coding RNA …, 2016 - Elsevier
Recent RNA sequencing studies have revealed that most of the human genome is
transcribed, but very little of the total transcriptomes has the ability to encode proteins. Long …

[HTML][HTML] Non-coding RNAs: the cancer genome dark matter that matters!

H Ling, L Girnita, O Buda, GA Calin - Clinical Chemistry and …, 2017 - degruyter.com
Protein-coding genes comprise only 3% of the human genome, while the genes that are
transcribed into RNAs but do not code for proteins occupy majority of the genome. Once …

[HTML][HTML] Long noncoding RNAs as promising biomarkers in cancer

O Beylerli, I Gareev, A Sufianov, T Ilyasova… - Non-coding RNA …, 2022 - Elsevier
Despite many advances in diagnosis and therapy (surgery, radiation therapy,
chemotherapy), cancer remains one of the most important public health problems …